Ki-67 index assessment on FNA specimens of gastrointestinal stromal tumor: Correlation with mitotic rate and potential predictive value for risk stratification

被引:4
|
作者
Wang, Xi [1 ]
Abi-Raad, Rita [1 ]
Tang, Haiming [1 ]
Cai, Guoping [1 ,2 ]
机构
[1] Yale Univ, Dept Pathol, Sch Med, Cedar St,CB 506B, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA
基金
美国国家卫生研究院;
关键词
fine-needle aspiration; gastrointestinal stromal tumor; Ki-67; index; prognosis; risk stratification; FINE-NEEDLE-ASPIRATION; PROGNOSTIC-FACTOR; CELL-BLOCK; DIAGNOSIS; CYTOLOGY; MANAGEMENT; BIOPSY;
D O I
10.1002/cncy.22630
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Risk assessment of gastrointestinal stromal tumor (GIST) is challenging on cytology specimens. This study aims to determine whether Ki-67 index evaluated on fine-needle aspiration (FNA) specimens can correlate with the mitotic rate of GIST in surgical specimens and provide further risk assessment. Methods Cases with cell blocks containing adequate tumor cells and surgical resections were included. Ki-67 immunostain was retrospectively performed on cell block sections, and Ki-67 index was calculated on the "hot spot" areas. Results This study included 50 GIST cases from stomach (n = 45; 90%), duodenum (n = 4; 8%), and distal esophagus (n = 1; 2%). The tumor size ranged from 1.5 cm to 21 cm (mean, 5.4 cm). Based on the mitotic count, 37 GISTs (74%) had low mitotic rate (LMR) and 13 GISTs (26%) had high mitotic rate (HMR). The spindle cell, epithelioid, and mixed types accounted for 60%, 14%, and 26% of GIST, respectively. Ki-67 index counted on cell block sections correlated well with mitotic count evaluated in surgical specimens (r = 0.8031). Mean Ki-67 index was higher in HMR than LMR groups (3.5% vs. 1%, p < .001). The receiver operating characteristic curve using Ki-67 index to predict mitotic rate was further analyzed, and area under the curve was 0.839. Using a cutoff of 2.5% yielded a sensitivity of 70% at 92% specificity. Conclusions This study demonstrates good correlations between Ki-67 index and mitotic count or risk stratification, suggesting that Ki-67 index evaluated on cytology specimens may offer a promising approach to preoperatively predict the mitotic rate and risk of GIST.
引用
收藏
页码:974 / 982
页数:9
相关论文
共 40 条
  • [21] Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis
    Pyo, Jung-Soo
    Kang, Guhyun
    Sohn, Jin Hee
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2016, 31 (02): : E204 - E210
  • [22] Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients
    Liu, Xuechao
    Qiu, Haibo
    Zhang, Peng
    Feng, Xingyu
    Chen, Tao
    Li, Yong
    Tao, Kaixiong
    Li, Guoxin
    Sun, Xiaowei
    Zhou, Zhiwei
    HUMAN PATHOLOGY, 2018, 74 : 17 - 24
  • [23] Proliferation markers RacGAP1 and Ki-67 in gastrointestinal stromal tumors by immunohistochemistry with respect to clinicopathological features and different risk stratification systems
    Sahin, Sevinc
    Ekinci, Ozgur
    Seckin, Selda
    Dursun, Ayse
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (12): : 11723 - 11736
  • [24] A Comparative Analysis: Ki-67 vs. PHH3 for Risk Prediction in Gastrointestinal Stromal Tumors (GISTs); Higher Ki-67 Proliferation Index Predicts Shorter Progression-Free Survival
    Rammal, Rayan
    Bedell, Mariel
    Baki, M-Nasan Abdul
    Shaker, Nuha
    Neyaz, Azfar
    Wilhelm, Alyeesha
    Abukhiran, Ibrahim
    LABORATORY INVESTIGATION, 2024, 104 (03) : S797 - S799
  • [25] Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors
    Arnaud Uguen
    Gwenaël Conq
    Laurent Doucet
    Matthieu Talagas
    Sebastian Costa
    Marc De Braekeleer
    Pascale Marcorelles
    Virchows Archiv, 2015, 467 : 47 - 54
  • [26] Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors
    Uguen, Arnaud
    Conq, Gwenael
    Doucet, Laurent
    Talagas, Matthieu
    Costa, Sebastian
    De Braekeleer, Marc
    Marcorelles, Pascale
    VIRCHOWS ARCHIV, 2015, 467 (01) : 47 - 54
  • [27] Evaluation of Alternative Risk Stratification Systems in a Large Series of Solitary Fibrous Tumors with Molecular Findings and Ki-67 Index Data: Do They Improve Risk Assessment?
    Machado, Isidro
    Bujeda, Alvaro Blazquez
    Giner, Francisco
    Morales, Maria Gema Nieto
    Cruz, Julia
    Lavernia, Javier
    Navarro, Samuel
    Ferrandez, Antonio
    Ruiz-Sauri, Amparo
    Llombart-Bosch, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [28] IMMUNOCYTOCHEMICAL (IC) ASSESSMENT OF TUMOR-CELL PROLIFERATIVE INDEX (PI) - APPLICATION OF MONOCLONAL-ANTIBODY (MAB) KI-67 TO FINE NEEDLE ASPIRATION (FNA) SMEARS
    STANLEY, M
    HENRY, M
    LABORATORY INVESTIGATION, 1989, 60 (01) : A91 - A91
  • [29] CORRELATION OF KI-67 ANTIGEN EXPRESSION WITH MITOTIC FIGURE INDEX AND TUMOR GRADE IN BREAST CARCINOMAS USING THE NOVEL PARAFFIN-REACTIVE MIB1 ANTIBODY
    WEIDNER, N
    MOORE, DH
    VARTANIAN, R
    HUMAN PATHOLOGY, 1994, 25 (04) : 337 - 342
  • [30] Evaluation of Ki67 Index in Endoscopic Ultrasound-Guided Fine Needle Aspiration Samples for the Assessment of Malignancy Risk in Gastric Gastrointestinal Stromal Tumors
    Seven, Gulseren
    Kochan, Koray
    Caglar, Erkan
    Kiremitci, Sercan
    Koker, Ibrahim Hakki
    Senturk, Hakan
    DIGESTIVE DISEASES, 2021, 39 (04) : 407 - 414